Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injury
Sándor Bátkai(National Institutes of Health), Pál Pacher(National Institutes of Health), Osama N. El‐Assal(Akron Children's Hospital), György Haskó(Columbia University), Douglas Osei‐Hyiaman(Tokyo Medical and Dental University), Partha Mukhopadhyay(National Institutes of Health), Mohanraj Rajesh(Institute of Medical Sciences), Judith Harvey‐White(National Institute on Alcohol Abuse and Alcoholism), John W. Huffman(Atrium Health Wake Forest Baptist), Feng Hong(AbbVie (United States)), Bin Gao(National Institute on Alcohol Abuse and Alcoholism), George Kunos(National Institute on Alcohol Abuse and Alcoholism), Anjum Jafri(National Institute on Alcohol Abuse and Alcoholism), Hao Pan(Chinese Academy of Sciences)
Cited by 240
Related Papers
Cardiac fibroblast–derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy
|Journal of Clinical Investigation|2014|993
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
|Journal of Clinical Investigation|2005|985
Activation of the Peripheral Endocannabinoid System in Human Obesity
|Diabetes|2005|690
The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy
|Nature Communications|2012|614